PubRank

Claudio Moretti

Author PubWeight™ 61.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol 2012 2.97
2 Cardiac remote ischaemic preconditioning reduces periprocedural myocardial infarction for patients undergoing percutaneous coronary interventions: a meta-analysis of randomised clinical trials. EuroIntervention 2014 2.30
3 Coronary computed tomographic angiography for detection of coronary artery disease in patients presenting to the emergency department with chest pain: a meta-analysis of randomized clinical trials. Eur Heart J Cardiovasc Imaging 2012 2.19
4 Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry. J Am Coll Cardiol 2008 1.73
5 Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: a meta-regression of randomized clinical trials. Atherosclerosis 2012 1.63
6 Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry. Eur Heart J 2008 1.58
7 Early and long-term results of percutaneous coronary intervention for unprotected left main trifurcation disease. Catheter Cardiovasc Interv 2009 1.42
8 Patent foramen ovale treatment strategy: an Italian large prospective study. J Cardiovasc Med (Hagerstown) 2014 1.41
9 Very long-term results comparing a simple versus a complex stenting strategy in the treatment of coronary bifurcation lesions. Catheter Cardiovasc Interv 2009 1.39
10 Results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease according to left ventricular systolic function. Catheter Cardiovasc Interv 2010 1.39
11 TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients. Contemp Clin Trials 2012 1.26
12 Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy. Eur Heart J 2011 1.26
13 Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention. Am Heart J 2008 1.10
14 Iatrogenic left internal mammary artery-coronary vein anastomosis treated with covered stent deployment via retrograde percutaneous coronary sinus approach. Catheter Cardiovasc Interv 2006 1.07
15 Comparison of mortality rates in women versus men presenting with ST-segment elevation myocardial infarction. Am J Cardiol 2010 1.02
16 A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease. Am Heart J 2007 1.02
17 The retrograde coronary approach for chronic total occlusions: mid-term results and technical tips & tricks. J Interv Cardiol 2007 0.99
18 Remote ischaemic preconditioning in coronary artery bypass surgery: a meta-analysis. Heart 2012 0.99
19 Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. Eur Heart J 2013 0.98
20 Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention. Am J Cardiol 2007 0.97
21 Prevalence and non-invasive predictors of left main or three-vessel coronary disease: evidence from a collaborative international meta-analysis including 22 740 patients. Heart 2012 0.96
22 Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry. Circulation 2007 0.95
23 Idiopathic thrombocytopenic purpura and percutaneous coronary stenting: a dangerous duo? Int J Cardiol 2007 0.94
24 International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. Am Heart J 2010 0.94
25 A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions. Acta Cardiol 2009 0.86
26 Percutaneous coronary intervention for small vessel coronary artery disease. Cardiovasc Revasc Med 2010 0.86
27 Gender differences in patients undergoing TAVI: a multicentre study. EuroIntervention 2013 0.85
28 Mapping brain circuit function in vivo using two-photon fluorescence microscopy. Microsc Res Tech 2014 0.84
29 Update on dedicated bifurcation stents. J Interv Cardiol 2009 0.84
30 Percutaneous coronary intervention on left main coronary artery trifurcation. Heart Vessels 2008 0.84
31 Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients. Clin Res Cardiol 2010 0.83
32 Inaccuracy of available surgical risk scores to predict outcomes after transcatheter aortic valve replacement. J Cardiovasc Med (Hagerstown) 2013 0.83
33 Immediate and medium-term outcomes following the treatment of very long (> or =50 mm) chronic total coronary artery occlusions. J Invasive Cardiol 2004 0.82
34 Retrograde percutaneous recanalization of coronary chronic total occlusions: outcomes from 17 patients. Int J Cardiol 2007 0.82
35 Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter "real-world" registry. Cardiol J 2016 0.81
36 Impact of access on TAVI procedural and midterm follow-up: a meta-analysis of 13 studies and 10,468 patients. J Interv Cardiol 2014 0.80
37 30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study. Int J Cardiol 2012 0.80
38 Sirolimus-eluting stent implantation for bare-metal in-stent restenosis: is there any evidence for a late catch-up phenomenon? J Cardiovasc Med (Hagerstown) 2008 0.80
39 Diffuse coronary disease: short- and long-term outcome after percutaneous coronary intervention. Acta Cardiol 2013 0.80
40 Percutaneous coronary intervention in nonagenarian: a meta-analysis of observational studies. J Cardiovasc Med (Hagerstown) 2013 0.80
41 Impact of routine angiographic follow-up after percutaneous coronary drug-eluting stenting for unprotected left main disease: the Turin Registry. Clin Res Cardiol 2010 0.80
42 One-year follow-up of conduction disturbances following transcatheter aortic valve implantation. J Cardiovasc Med (Hagerstown) 2015 0.80
43 Acute coronary syndrome in HIV patients: from pathophysiology to clinical practice. Cardiovasc Diagn Ther 2012 0.79
44 Discontinuation of dual antiplatelet therapy over 12 months after acute coronary syndromes increases risk for adverse events in patients treated with percutaneous coronary intervention: systematic review and meta-analysis. J Interv Cardiol 2014 0.78
45 BleeMACS: rationale and design of the study. J Cardiovasc Med (Hagerstown) 2016 0.78
46 Impact of diabetes mellitus on early and long-term results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease. J Cardiovasc Med (Hagerstown) 2008 0.78
47 Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: evidence from a meta-regression. Am Heart J 2007 0.78
48 Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study). J Am Coll Cardiol 2009 0.78
49 Long-term clinical and angiographic outcomes of treatment of unprotected left main coronary artery stenosis with sirolimus-eluting stents. Am J Cardiol 2007 0.77
50 Use and misuse of multivariable approaches in interventional cardiology studies on drug-eluting stents: a systematic review. J Interv Cardiol 2012 0.77
51 In vivo coronary plaque histology in patients with stable and acute coronary syndromes: relationships with hyperlipidemic status and statin treatment. Atherosclerosis 2006 0.77
52 Prevalence and predictors of long corrected QT interval in HIV-positive patients: a multicenter study. J Cardiovasc Med (Hagerstown) 2017 0.77
53 A meta-analysis investigating incidence and features of stroke in HIV-infected patients in the highly active antiretroviral therapy era. J Cardiovasc Med (Hagerstown) 2015 0.76
54 Making sense of the recent meta-analytical confusion concerning the safety of drug-eluting stents. EuroIntervention 2007 0.76
55 Drugs for attention deficit-hyperactivity disorder do not increase the mid-term risk of sudden death in children: a meta-analysis of observational studies. Int J Cardiol 2013 0.76
56 Choosing the best first line oral drug agent in patients with pulmonary hypertension: evidence from a network meta-analysis. Int J Cardiol 2013 0.76
57 Outcomes of Patients Undergoing Balloon Aortic Valvuloplasty in the TAVI Era: A Multicenter Registry. J Invasive Cardiol 2015 0.76
58 Heart failure in patients with human immunodeficiency virus: a review of the literature. J Cardiovasc Med (Hagerstown) 2015 0.76
59 The future of new aortic valve replacement approaches. Future Cardiol 2010 0.76
60 Percutaneous coronary stenting in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis. EuroIntervention 2007 0.75
61 Transradial access without preliminary Allen test--letter of comment on Rhyne et al. Catheter Cardiovasc Interv 2011 0.75
62 Changing of SYNTAX score performing fractional flow reserve in multivessel coronary artery disease. J Cardiovasc Med (Hagerstown) 2012 0.75
63 Meta-analysis of coronary CT angiography in the emergency department: reply. Eur Heart J Cardiovasc Imaging 2013 0.75
64 Remote ischaemic preconditioning: the missing link between bench and bedside. EuroIntervention 2014 0.75
65 Drug-eluting stent implantation in primary angioplasty of an anomalous left main coronary artery: diagnostic and technical considerations. Ital Heart J 2004 0.75
66 Intra-arterial lidocaine versus saline to reduce peri-procedural discomfort in patients undergoing percutaneous trans-radial or trans-ulnar coronary procedures. Acta Cardiol 2011 0.75
67 An iatrogenic atrioventricular septal defect that developed following transfemoral TAVI. J Heart Valve Dis 2014 0.75
68 Transjugular tricuspid valve-in-valve implantation. Heart Lung Circ 2013 0.75
69 Effect of a novel drug-eluted balloon coated with genistein before stent implantation in porcine coronary arteries. Clin Res Cardiol 2008 0.75
70 [Left main coronary stenting is safe and effective and is a valuable alternative to coronary artery bypass graft surgery]. G Ital Cardiol (Rome) 2009 0.75
71 Which is the best anti-aggregant or anti-coagulant therapy after TAVI? A propensity matched analysis from the ITER registry. The management of DAPT after TAVI. EuroIntervention 2017 0.75
72 Current management of unprotected left main coronary artery disease: run-in survey of the RITMO (Registro Italiano sul Trattamento del tronco coMune non protettO) study. Int J Cardiol 2008 0.75
73 ROTational AThErectomy in acute coronary syndrome: early and midterm outcomes from a multicentre registry. EuroIntervention 2016 0.75
74 Retrograde septal approach for a challenging chronic total occlusion of the right coronary artery. J Cardiovasc Med (Hagerstown) 2008 0.75
75 Sirolimus-eluting stents for the treatment of bare-metal in-stent restenosis: long-term clinical follow up. J Invasive Cardiol 2007 0.75
76 In-hospital and midterm clinical outcomes of rotational atherectomy followed by stent implantation: the ROTATE multicentre registry. EuroIntervention 2016 0.75
77 Angiographic Follow-Up in Patients With Coronary Artery Disease: Is There a Window to Be Definitively Closed? JACC Cardiovasc Interv 2017 0.75
78 Transapical implantation of an Edwards SAPIEN XT in a degenerated mitral bioprosthesis without fluoroscopic landmarks. J Card Surg 2014 0.75
79 Corrigendum: Simultaneous high-speed imaging and optogenetic inhibition in the intact mouse brain. Sci Rep 2017 0.75
80 Sirolimus-Eluting Stents vs Bare Metal Stents for the treatment of unprotected left main coronary artery stenosis. EuroIntervention 2006 0.75
81 Short- and long-term outcomes of percutaneous coronary interventions in patients with severe left ventricular dysfunction. EuroIntervention 2007 0.75
82 Incidence, predictors, and impact on prognosis of systolic pulmonary artery pressure and its improvement after transcatheter aortic valve implantation: a multicenter registry. J Invasive Cardiol 2015 0.75
83 [Left main coronary artery stenosis]. G Ital Cardiol (Rome) 2008 0.75
84 Complete or incomplete coronary revascularization in patients with myocardial infarction and multivessel disease. A propensity score analysis from the "real life" BleeMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registry. EuroIntervention 2017 0.75
85 High sensitive TROponin levels In Patients with Chest pain and kidney disease: A multicenter registry - The TROPIC study. Cardiol J 2017 0.75
86 Safety of drug-coated stents. Expert Opin Drug Saf 2008 0.75
87 Paclitaxel-eluting stents for the treatment of complex coronary lesions: immediate and 12-month results. J Cardiovasc Med (Hagerstown) 2007 0.75
88 Relationship between ventricular pressure and coronary artery disease in asymptomatic adult heart transplant recipients. J Cardiovasc Med (Hagerstown) 2017 0.75
89 Dual oral antiplatelet therapy and unplanned surgery: possible role for intravenous platelet glycoprotein receptor inhibitors. J Cardiovasc Med (Hagerstown) 2011 0.75
90 Postpartum valve thrombosis: a happy ending thriller. J Cardiovasc Med (Hagerstown) 2015 0.75
91 Impact of multivessel stenting on top of percutaneous revascularization for unprotected left main disease in the drug-eluting stent era: insights from the Turin registry. J Cardiovasc Med (Hagerstown) 2009 0.75
92 Transcatheter aortic valve implantation in low ejection fraction/low transvalvular gradient patients: the rule of 40. J Cardiovasc Med (Hagerstown) 2017 0.75
93 [Impact of concomitant use of P2Y12 inhibitors and proton pump inhibitors on ischemia events in patients with acute coronary syndrome in real world]. Zhonghua Yi Xue Za Zhi 2016 0.75
94 A prospective multicentre observational study on the management of unprotected left main coronary artery disease: rationale and design of the Registro Italiano sul Trattamento del tronco comune non protetto study. J Cardiovasc Med (Hagerstown) 2008 0.75
95 Impact on prognosis of periprocedural myocardial infarction after percutaneous coronary intervention. J Interv Cardiol 2014 0.75